Eotaxin Level in Induced Sputum Is Increased in Patients with Bronchial Asthma and in Smokers

Respiration ◽  
2003 ◽  
Vol 70 (6) ◽  
pp. 600-605 ◽  
Author(s):  
Katsumaru Yamamoto ◽  
Shingo Takanashi ◽  
Yukihiro Hasegawa ◽  
Yutaka Kanehira ◽  
Mitsuaki Kaizuka ◽  
...  
2004 ◽  
Vol 137 (1) ◽  
pp. 50-52
Author(s):  
E. A. Gereng ◽  
I. V. Sukhodolo ◽  
R. I. Pleshko ◽  
L. M. Ogorodova ◽  
O. S. Kobyakova ◽  
...  

2014 ◽  
Vol 63 (1) ◽  
pp. 21-27 ◽  
Author(s):  
Nezar R. Mohamed ◽  
Elham A. Abdel Ghany ◽  
Khalid M. Othman

Doctor Ru ◽  
2021 ◽  
Vol 20 (10) ◽  
pp. 25-30
Author(s):  
I.A. Fedorov ◽  
◽  
O.G. Rybakova ◽  
E.A. Goreva ◽  
◽  
...  

Study Objective: To analyze the microbiota of the lower respiratory tract in children with bronchial asthma, depending on the severity, period of the disease and inflammatory phenotype, as well as to compare the obtained data on the microbiota with the data obtained two decades ago. Study Design: The study is organized in a cross-sectional manner. Materials and Methods. The study involved 66 children with bronchial asthma aged 6 to 18 years old. All participants had their microbiota of the bronchial tree studied by bacteriological examination of induced sputum samples; in some children, the cytology of induced sputum was analyzed (n = 36). Statistical analysis was performed using Statistica 10.0. Intergroup differences in qualitative parameters were evaluated using χ2 and Fisher’s exact test. Statistically significant changes were are p < 0.05. Study Results. The predominant flora of the lower respiratory tract in children with bronchial asthma was Streptococcus spp. (66.7%), Staphylococcus spp. (33.3%) and Neisseria spp. (30.3%). There were no significant differences in the spectrum of the microflora of the bronchial tree depending on the period (exacerbation/remission) and the severity of the disease. When analysing the spectrum of the microbiota depending on the inflammatory phenotype, it was found that all sputum samples from patients with neutrophilic inflammatory phenotype were inoculated with Streptococcus spp., and in 25% of cases it was Streptococcus pneumonia. In patients with an eosinophilic inflammatory phenotype, most common was Staphylococcus spp. (75.0%), in particular Staphylococcus aureus (62.5%). When analysing the spectrum of microflora in a temporal aspect, it turned out that 20 years ago 41.2% of sputum samples did no demonstrate microflora growth. The growth of Streptococcus spp. and, in particular, Streptococcus pneumoniae, was significantly less frequent, Staphylococcus spp. were shown with the same frequency as now. Conclusion. The relationship between bronchial asthma and airway microbiota is complex and controversial. The revealed patterns show that the severity of bronchial asthma and the period of the disease do not affect the spectrum of microflora; however, statistically significant differences were found depending on the inflammatory phenotype. Since asthma phenotypes are immunological and physical-chemical characteristics of the mucous membrane of lower respiratory tract, this may be the reason for their selective impact of the microbial growth in respiratory tract, and on their biogeography, thus impacting the course and management of bronchial asthma. Keywords: bronchial asthma, respiratory tract microbiota, inflammatory phenotype, children.


2011 ◽  
Vol 8 (4) ◽  
pp. 49-54
Author(s):  
D V Terekhov ◽  
Nataliya Mikhaylovna Nenasheva ◽  
D V Terekhov ◽  
N M Nenasheva

Background. To study the efficacy and safety of inhaled form of ruzam in adult patients with persistent mild and moderate atopic bronchial asthma (ba). Materials and methods. a placebo-controlled prospective, randomized, open label study of an efficacy of ruzam a solution for inhalations (in bottles on 2,5 or 5 ml) on 2,5 ml onсe a day through nebulizer during 2 weeks was conducted in adult asthmatic patients. The efficacy of therapy was evaluated by dynamics of symptoms and requirement in ƒ2-agonists, besides PEfr, spirometry, bronchial hyperresponsiveness (bhr), asthma control test (aCT ), level of the markers of the allergic inflammation were performed. Results. reduction of bа symptoms, increase morning PEfr, decrease of bhr and NОex level in patients who received ruzam compared with control group was observed. achievement of clinical control of bа in patients treated by ruzam was accompanied by statistically significant positive dynamics of markers of inflammation (ifNg, ECP) in blood serum and in supernatant of the induced sputum. it testifies about anti-inflammatory influence of ruzam. Conclusion. inhaled therapy with ruzam in a complex with iNCs basic therapy is an effective and safe method of treatment of persistent atopic bronchial asthma. This combination allows to reach clinical and functional control of ba faster and to reduce inflammation markers in blood serum and induced sputum.


2018 ◽  
Vol 90 (3) ◽  
pp. 25-32
Author(s):  
I A Soloveva ◽  
E A Sobko ◽  
I V Demko ◽  
A Yu Kraposhina ◽  
M M Loktionova ◽  
...  

Aim. To estimate changes of cellular structure of the induced sputum at young patients with bronchial asthma at interrelations with BMI and level of cytokines in blood plasma. Materials and methods. 164 patients with bronchial asthma were divided into 2 groups taking into BMI: the 1st group included patients with bronchial asthma and BMI from 18 to 25 kg/m2, patients with bronchial asthma and BMI from 30 to 40 kg/m2 entered into the 2nd group. The group of control was made by 40 almost healthy volunteers. Estimated existence of excess weight and defined obesity degree according to recommendations of World Health Organization. Studied the level of control of bronchial asthma, cellular structure of the induced sputum, the IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-15, IL-17, TNF-α, INF-γ levels in plasma of peripheral blood. Results. There are presented the results of the research of cellular profile of the induced sputum and profile of cytokines at patients with bronchial asthma depending on BMI and severity of the disease. The received results testify to prevalence of eosinophilic type of an inflammation in the group of patients with BMI less than 25 kg/m2 whereas at patients mainly paucigranulation inflammation decided on obesity. The highest content of the Il-17 was registered at patients with bronchial asthma and obesity as in comparison with indicators of patients with normal BMI, and with almost healthy that, perhaps, is the reason of low effect of steroid therapy at these patients. Conclusion. Endotype assessment before basic antiinflammatory therapy at patients with the first time diagnosed bronchial asthma, will be able to help with selection of the most optimum treatment to each specific patient.


Sign in / Sign up

Export Citation Format

Share Document